HERON THERAPEUTICS, INC. /DE/ (HRTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$10.03M2010: -$7.35M2011: -$11.81M2012: -$23.35M2013: -$55.28M2014: -$76.37M2015: -$97.59M2016: -$173.14M2017: -$197.48M2018: -$178.84M2019: -$204.75M2020: -$227.28M2021: -$220.68M2022: -$182.02M2023: -$110.56M2024: -$13.58M2025: -$20.20M-$20.20M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$20.20M-48.7%
2024-$13.58M+87.7%
2023-$110.56M+39.3%
2022-$182.02M+17.5%
2021-$220.68M+2.9%
2020-$227.28M-11.0%
2019-$204.75M-14.5%
2018-$178.84M+9.4%
2017-$197.48M-14.1%
2016-$173.14M-77.4%
2015-$97.59M-27.8%
2014-$76.37M-38.1%
2013-$55.28M-136.8%
2012-$23.35M-97.6%
2011-$11.81M-60.8%
2010-$7.35M+26.7%
2009-$10.03M